Zimmer Biomet Holdings’s Registered Fixed and Floating Rate Notes Offering

Cravath represented the underwriters, led by Bank of America Merrill Lynch, Citigroup, Mitsubishi UFJ Financial Group, SMBC Nikko, Credit Suisse, J.P. Morgan Securities and Wells Fargo Securities, in connection with the $750 million registered fixed and floating rate notes offering of Zimmer Biomet Holdings, Inc., a global leader in musculoskeletal healthcare. The transaction closed on March 19, 2018.

The Cravath team included partner Bill Whelan and associate Holden K. Sumner on securities matters, and associate Peter W. Rogers and foreign associate attorney Jean‑Baptiste Frantz on tax matters. Samuel A. Lifton also worked on securities matters.